ArticleBritish journal of cancer2020

TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours.

Yurina Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.